0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Vector Development Service Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-11U6327
Home | Market Reports | Computers & Electronics| Software
Global Viral Vector Development Service Market Insights Forecast to 2028
BUY CHAPTERS

Global Viral Vector Development Service Market Research Report 2025

Code: QYRE-Auto-11U6327
Report
January 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Vector Development Service Market

The global market for Viral Vector Development Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Viral Vector Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Viral Vector Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Viral Vector Development Service in Pharmaceutical Manufacturers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Viral Vector Development Service include UJIFILM Diosynth Biotechnologies, Sanofi, Spark Therapeutics, UniQure, MassBiologics, FinVector, Thermo Fisher Scientific (Brammer Bio), Cell and Gene Therapy Catapult, Cobra Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Development Service.
The Viral Vector Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Viral Vector Development Service Market Report

Report Metric Details
Report Name Viral Vector Development Service Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company UJIFILM Diosynth Biotechnologies, Sanofi, Spark Therapeutics, UniQure, MassBiologics, FinVector, Thermo Fisher Scientific (Brammer Bio), Cell and Gene Therapy Catapult, Cobra Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Viral Vector Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Viral Vector Development Service Market report?

Ans: The main players in the Viral Vector Development Service Market are UJIFILM Diosynth Biotechnologies, Sanofi, Spark Therapeutics, UniQure, MassBiologics, FinVector, Thermo Fisher Scientific (Brammer Bio), Cell and Gene Therapy Catapult, Cobra Biologics

What are the Application segmentation covered in the Viral Vector Development Service Market report?

Ans: The Applications covered in the Viral Vector Development Service Market report are Pharmaceutical Manufacturers, Biotechnology Companies, Research Institutes

What are the Type segmentation covered in the Viral Vector Development Service Market report?

Ans: The Types covered in the Viral Vector Development Service Market report are Retroviral Vectors, Lentiviral Vectors, Adenoviral Vectors, Adeno-associated Viral Vectors, Others Viral Vectors

Recommended Reports

Viral Vector Services

Gene & Cell Therapy

Viral Vaccine Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Adeno-associated Viral Vectors
1.2.6 Others Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vector Development Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Manufacturers
1.3.3 Biotechnology Companies
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Development Service Market Perspective (2020-2031)
2.2 Global Viral Vector Development Service Growth Trends by Region
2.2.1 Global Viral Vector Development Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Vector Development Service Historic Market Size by Region (2020-2025)
2.2.3 Viral Vector Development Service Forecasted Market Size by Region (2026-2031)
2.3 Viral Vector Development Service Market Dynamics
2.3.1 Viral Vector Development Service Industry Trends
2.3.2 Viral Vector Development Service Market Drivers
2.3.3 Viral Vector Development Service Market Challenges
2.3.4 Viral Vector Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Development Service Players by Revenue
3.1.1 Global Top Viral Vector Development Service Players by Revenue (2020-2025)
3.1.2 Global Viral Vector Development Service Revenue Market Share by Players (2020-2025)
3.2 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector Development Service Revenue
3.4 Global Viral Vector Development Service Market Concentration Ratio
3.4.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2024
3.5 Global Key Players of Viral Vector Development Service Head office and Area Served
3.6 Global Key Players of Viral Vector Development Service, Product and Application
3.7 Global Key Players of Viral Vector Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Development Service Breakdown Data by Type
4.1 Global Viral Vector Development Service Historic Market Size by Type (2020-2025)
4.2 Global Viral Vector Development Service Forecasted Market Size by Type (2026-2031)
5 Viral Vector Development Service Breakdown Data by Application
5.1 Global Viral Vector Development Service Historic Market Size by Application (2020-2025)
5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Vector Development Service Market Size (2020-2031)
6.2 North America Viral Vector Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Vector Development Service Market Size by Country (2020-2025)
6.4 North America Viral Vector Development Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Development Service Market Size (2020-2031)
7.2 Europe Viral Vector Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Vector Development Service Market Size by Country (2020-2025)
7.4 Europe Viral Vector Development Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Development Service Market Size (2020-2031)
8.2 Asia-Pacific Viral Vector Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Vector Development Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Vector Development Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Development Service Market Size (2020-2031)
9.2 Latin America Viral Vector Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Vector Development Service Market Size by Country (2020-2025)
9.4 Latin America Viral Vector Development Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Development Service Market Size (2020-2031)
10.2 Middle East & Africa Viral Vector Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Vector Development Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Vector Development Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UJIFILM Diosynth Biotechnologies
11.1.1 UJIFILM Diosynth Biotechnologies Company Details
11.1.2 UJIFILM Diosynth Biotechnologies Business Overview
11.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Introduction
11.1.4 UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2020-2025)
11.1.5 UJIFILM Diosynth Biotechnologies Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Viral Vector Development Service Introduction
11.2.4 Sanofi Revenue in Viral Vector Development Service Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Viral Vector Development Service Introduction
11.3.4 Spark Therapeutics Revenue in Viral Vector Development Service Business (2020-2025)
11.3.5 Spark Therapeutics Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector Development Service Introduction
11.4.4 UniQure Revenue in Viral Vector Development Service Business (2020-2025)
11.4.5 UniQure Recent Development
11.5 MassBiologics
11.5.1 MassBiologics Company Details
11.5.2 MassBiologics Business Overview
11.5.3 MassBiologics Viral Vector Development Service Introduction
11.5.4 MassBiologics Revenue in Viral Vector Development Service Business (2020-2025)
11.5.5 MassBiologics Recent Development
11.6 FinVector
11.6.1 FinVector Company Details
11.6.2 FinVector Business Overview
11.6.3 FinVector Viral Vector Development Service Introduction
11.6.4 FinVector Revenue in Viral Vector Development Service Business (2020-2025)
11.6.5 FinVector Recent Development
11.7 Thermo Fisher Scientific (Brammer Bio)
11.7.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Introduction
11.7.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2020-2025)
11.7.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.8 Cell and Gene Therapy Catapult
11.8.1 Cell and Gene Therapy Catapult Company Details
11.8.2 Cell and Gene Therapy Catapult Business Overview
11.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Introduction
11.8.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2020-2025)
11.8.5 Cell and Gene Therapy Catapult Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Details
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Viral Vector Development Service Introduction
11.9.4 Cobra Biologics Revenue in Viral Vector Development Service Business (2020-2025)
11.9.5 Cobra Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Viral Vector Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Retroviral Vectors
 Table 3. Key Players of Lentiviral Vectors
 Table 4. Key Players of Adenoviral Vectors
 Table 5. Key Players of Adeno-associated Viral Vectors
 Table 6. Key Players of Others Viral Vectors
 Table 7. Global Viral Vector Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Viral Vector Development Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Viral Vector Development Service Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Viral Vector Development Service Market Share by Region (2020-2025)
 Table 11. Global Viral Vector Development Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Viral Vector Development Service Market Share by Region (2026-2031)
 Table 13. Viral Vector Development Service Market Trends
 Table 14. Viral Vector Development Service Market Drivers
 Table 15. Viral Vector Development Service Market Challenges
 Table 16. Viral Vector Development Service Market Restraints
 Table 17. Global Viral Vector Development Service Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Viral Vector Development Service Market Share by Players (2020-2025)
 Table 19. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Development Service as of 2024)
 Table 20. Ranking of Global Top Viral Vector Development Service Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Viral Vector Development Service Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Viral Vector Development Service, Headquarters and Area Served
 Table 23. Global Key Players of Viral Vector Development Service, Product and Application
 Table 24. Global Key Players of Viral Vector Development Service, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Viral Vector Development Service Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Viral Vector Development Service Revenue Market Share by Type (2020-2025)
 Table 28. Global Viral Vector Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Viral Vector Development Service Revenue Market Share by Type (2026-2031)
 Table 30. Global Viral Vector Development Service Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Viral Vector Development Service Revenue Market Share by Application (2020-2025)
 Table 32. Global Viral Vector Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Viral Vector Development Service Revenue Market Share by Application (2026-2031)
 Table 34. North America Viral Vector Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Viral Vector Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Viral Vector Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Viral Vector Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Viral Vector Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Viral Vector Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Viral Vector Development Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Viral Vector Development Service Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Viral Vector Development Service Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Viral Vector Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Viral Vector Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Viral Vector Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Viral Vector Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Viral Vector Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Viral Vector Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 49. UJIFILM Diosynth Biotechnologies Company Details
 Table 50. UJIFILM Diosynth Biotechnologies Business Overview
 Table 51. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Product
 Table 52. UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 53. UJIFILM Diosynth Biotechnologies Recent Development
 Table 54. Sanofi Company Details
 Table 55. Sanofi Business Overview
 Table 56. Sanofi Viral Vector Development Service Product
 Table 57. Sanofi Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 58. Sanofi Recent Development
 Table 59. Spark Therapeutics Company Details
 Table 60. Spark Therapeutics Business Overview
 Table 61. Spark Therapeutics Viral Vector Development Service Product
 Table 62. Spark Therapeutics Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 63. Spark Therapeutics Recent Development
 Table 64. UniQure Company Details
 Table 65. UniQure Business Overview
 Table 66. UniQure Viral Vector Development Service Product
 Table 67. UniQure Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 68. UniQure Recent Development
 Table 69. MassBiologics Company Details
 Table 70. MassBiologics Business Overview
 Table 71. MassBiologics Viral Vector Development Service Product
 Table 72. MassBiologics Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 73. MassBiologics Recent Development
 Table 74. FinVector Company Details
 Table 75. FinVector Business Overview
 Table 76. FinVector Viral Vector Development Service Product
 Table 77. FinVector Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 78. FinVector Recent Development
 Table 79. Thermo Fisher Scientific (Brammer Bio) Company Details
 Table 80. Thermo Fisher Scientific (Brammer Bio) Business Overview
 Table 81. Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Product
 Table 82. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 83. Thermo Fisher Scientific (Brammer Bio) Recent Development
 Table 84. Cell and Gene Therapy Catapult Company Details
 Table 85. Cell and Gene Therapy Catapult Business Overview
 Table 86. Cell and Gene Therapy Catapult Viral Vector Development Service Product
 Table 87. Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 88. Cell and Gene Therapy Catapult Recent Development
 Table 89. Cobra Biologics Company Details
 Table 90. Cobra Biologics Business Overview
 Table 91. Cobra Biologics Viral Vector Development Service Product
 Table 92. Cobra Biologics Revenue in Viral Vector Development Service Business (2020-2025) & (US$ Million)
 Table 93. Cobra Biologics Recent Development
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources
 Table 97. Authors List of This Report


List of Figures
 Figure 1. Viral Vector Development Service Picture
 Figure 2. Global Viral Vector Development Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Viral Vector Development Service Market Share by Type: 2024 VS 2031
 Figure 4. Retroviral Vectors Features
 Figure 5. Lentiviral Vectors Features
 Figure 6. Adenoviral Vectors Features
 Figure 7. Adeno-associated Viral Vectors Features
 Figure 8. Others Viral Vectors Features
 Figure 9. Global Viral Vector Development Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Viral Vector Development Service Market Share by Application: 2024 VS 2031
 Figure 11. Pharmaceutical Manufacturers Case Studies
 Figure 12. Biotechnology Companies Case Studies
 Figure 13. Research Institutes Case Studies
 Figure 14. Viral Vector Development Service Report Years Considered
 Figure 15. Global Viral Vector Development Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Viral Vector Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Viral Vector Development Service Market Share by Region: 2024 VS 2031
 Figure 18. Global Viral Vector Development Service Market Share by Players in 2024
 Figure 19. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Development Service as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Viral Vector Development Service Revenue in 2024
 Figure 21. North America Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Viral Vector Development Service Market Share by Country (2020-2031)
 Figure 23. United States Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Viral Vector Development Service Market Share by Country (2020-2031)
 Figure 27. Germany Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Viral Vector Development Service Market Share by Region (2020-2031)
 Figure 35. China Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Viral Vector Development Service Market Share by Country (2020-2031)
 Figure 43. Mexico Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Viral Vector Development Service Market Share by Country (2020-2031)
 Figure 47. Turkey Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Viral Vector Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 51. Sanofi Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 52. Spark Therapeutics Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 53. UniQure Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 54. MassBiologics Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 55. FinVector Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 56. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 57. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 58. Cobra Biologics Revenue Growth Rate in Viral Vector Development Service Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global BYOD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11T6229
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Translation Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Z5964
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Archiving Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11S6221
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Point of Sale Automation System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11J6299
Fri Sep 12 00:00:00 UTC 2025

Add to Cart